The professor of Oncology in the Cancer Institute of Roswell Park is Mikhail Blagosklonny. He also takes part in the scientific study of cancer and aging. This scientist is behind the formulation of TOR in aging and the use of a cancer drug referred to as rapamycin. Blagosklonny graduated from the First Pavlov State Medical University of St. Petersburg. In 2002 he became an associate professor at the Network Medical College and later took the position of a senior scientist at Ordway Research Institute. His research is mainly based on two elements one is the cancer therapy which largely protect the normal skin from any damage, and the main mechanisms associated with aging and anti-aging drugs. He is the chief editor of Aging, Oncotarget and Cell Cycle. Moreover, he is one of editorial board of Cell Death and Differentiation and also involved in cancer biology and therapy.
Oncotarget is a journal that was formed in 2010. At the beginning it dealt mainly with issues surrounding cancer treatment and examination referred to as Oncology. However, with time it grew to accommodate other fields of Biomedicine. The issues are published on a weekly basis and they are printed once demanded. The journal is found on the online platforms and can be accessed freely. They have progressed and made major strides of including other medical fields like cardiology, pharmacy, neuroscience and microbiology. Year after year the journal has been ranked to be the best in the market. Check the journal at SCImago Journal & Country Rank.
The Oncotarget’s success is based on the qualified and passionate editors, the use of different online platforms which is widely used and the various strategies they use while publishing. The editors look careful at the manuscripts and evaluate them without looking at the race, citizenship or religious beliefs of the authors. Similarly, the decision on publication is not in any way political. The editorial team does not give any information outside the editorial board. All the information is confidential and the editors are not subjected to use the unpublished information. Another task for the editors is to look keenly at the manuscripts. On the other side peer review is of great importance since it guides the editors in decision making and to review on the work of the authors and identify where they are supposed to improve on. Oncotarget is published by Impact Journals.